Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan versus naratriptan for post-dural puncture headache in obstetric patients
PACTR201901888984937Phase 4Completed
- Sponsor
- Fayoum University Hospital
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in post-dural puncture headache (PDPH) comparing Sumatriptan arm, Naratriptan arm and Placebo arm (3 arms). Primary endpoint: Pain score after 72 hours. Started Mar 2017; status: completed.
02
Drugs
sumatriptannaratriptan
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on PACTR201901888984937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201901888984937.